Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cyanonitrosylferrate
2. Disodium Salt Nitroprusside
3. Ketostix
4. Naniprus
5. Nipride
6. Nipruton
7. Nitriate
8. Nitroferricyanide
9. Nitropress
10. Nitroprussiat Fides
11. Nitroprusside
12. Nitroprusside, Disodium Salt
13. Nitroprusside, Disodium Salt, Dihydrate
14. Nitroprusside, Sodium
15. Sodium Nitroprusside
1. Nitroprusside [who-dd]
2. Dtxsid2046963
3. 169d1260km
| Molecular Weight | 215.94 g/mol |
|---|---|
| Molecular Formula | C5FeN6O-2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 0 |
| Exact Mass | 215.948294 g/mol |
| Monoisotopic Mass | 215.948294 g/mol |
| Topological Polar Surface Area | 144 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | -2 |
| Complexity | 20 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 7 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Indicators and Reagents
Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh's Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)
Nitric Oxide Donors
A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
ABOUT THIS PAGE
31
PharmaCompass offers a list of 169D1260Km API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 169D1260Km manufacturer or 169D1260Km supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 169D1260Km manufacturer or 169D1260Km supplier.
PharmaCompass also assists you with knowing the 169D1260Km API Price utilized in the formulation of products. 169D1260Km API Price is not always fixed or binding as the 169D1260Km Price is obtained through a variety of data sources. The 169D1260Km Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 169D1260Km manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 169D1260Km, including repackagers and relabelers. The FDA regulates 169D1260Km manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 169D1260Km API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 169D1260Km supplier is an individual or a company that provides 169D1260Km active pharmaceutical ingredient (API) or 169D1260Km finished formulations upon request. The 169D1260Km suppliers may include 169D1260Km API manufacturers, exporters, distributors and traders.
169D1260Km Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 169D1260Km GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 169D1260Km GMP manufacturer or 169D1260Km GMP API supplier for your needs.
A 169D1260Km CoA (Certificate of Analysis) is a formal document that attests to 169D1260Km's compliance with 169D1260Km specifications and serves as a tool for batch-level quality control.
169D1260Km CoA mostly includes findings from lab analyses of a specific batch. For each 169D1260Km CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
169D1260Km may be tested according to a variety of international standards, such as European Pharmacopoeia (169D1260Km EP), 169D1260Km JP (Japanese Pharmacopeia) and the US Pharmacopoeia (169D1260Km USP).
